These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17469240)

  • 1. Size matters. What can we learn from a small randomized trial?
    Saltz L
    Onkologie; 2007 Apr; 30(4):167. PubMed ID: 17469240
    [No Abstract]   [Full Text] [Related]  

  • 2. [Initial results of randomized studies of metastatic colorectal carcinoma urge careful and controlled use of CPT-11].
    Klautke G; Fietkau R
    Strahlenther Onkol; 2002 Mar; 178(3):163-4. PubMed ID: 11962194
    [No Abstract]   [Full Text] [Related]  

  • 3. Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard?
    Schmoll HJ; Sargent D
    Lancet; 2007 Jul; 370(9582):105-107. PubMed ID: 17630019
    [No Abstract]   [Full Text] [Related]  

  • 4. Irinotecan/5-FU/leucovorin, oxaliplatin/5-FU/leucovorin, and oxaliplatin/irinotecan are each effective in the treatment of 5-FU-resistant advanced colorectal cancer.
    Fisher MD
    Clin Colorectal Cancer; 2001 Aug; 1(2):85-6. PubMed ID: 12445365
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
    Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Tang LN; Zhang W
    Chin Med J (Engl); 2006 Nov; 119(21):1829-33. PubMed ID: 17097039
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic chemotherapy for metastatic colorectal cancer: reasons to combine.
    Calvo E
    Clin Colorectal Cancer; 2002 Nov; 2(3):170-2. PubMed ID: 12482333
    [No Abstract]   [Full Text] [Related]  

  • 7. Always look at the bright side of drugs?
    Nygren P
    Acta Oncol; 2015 Feb; 54(2):145-7. PubMed ID: 25608927
    [No Abstract]   [Full Text] [Related]  

  • 8. [Systemic therapy for colorectal cancer].
    Pestalozzi BC; Jäger D; Knuth A
    Chirurg; 2005 Jun; 76(6):570-2, 574. PubMed ID: 15905968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turning point for colorectal cancer clinical trials.
    Meropol NJ
    J Clin Oncol; 2006 Jul; 24(21):3322-4. PubMed ID: 16849744
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better.
    Allegra C; George T; Yothers G
    J Natl Cancer Inst; 2011 Jan; 103(1):4-5. PubMed ID: 21123834
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized trial comparing the addition of oxaliplatin or irinotecan to high-dose leucovorin and 5-Fluorouracil intravenous bolus every two weeks in metastatic colorectal carcinoma: Southern Italy Cooperative Oncology Group 0103.
    Comella P
    Clin Colorectal Cancer; 2003 Nov; 3(3):186-9. PubMed ID: 14706179
    [No Abstract]   [Full Text] [Related]  

  • 12. Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomised phase II study.
    Price TJ; Townsend AR; Khattak A
    Ann Oncol; 2010 Oct; 21(10):2121; author reply 2121-2. PubMed ID: 20860991
    [No Abstract]   [Full Text] [Related]  

  • 13. Strategic options on behalf of patients with metastatic colorectal cancer: mass tumor murder versus serial tumor killing.
    Goldberg RM
    Onkologie; 2010; 33(6):291-2. PubMed ID: 20523091
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy of colorectal carcinoma].
    Lutz MP; Adler G
    Internist (Berl); 2001 Dec; 42(12):1567-8, 1571-6, 1578-82. PubMed ID: 11793596
    [No Abstract]   [Full Text] [Related]  

  • 15. Current perspectives in the treatment of metastatic colorectal cancer.
    Köhne CH; Folprecht G
    Ann Oncol; 2004; 15 Suppl 4():iv43-53. PubMed ID: 15477334
    [No Abstract]   [Full Text] [Related]  

  • 16. [Surgery and chemotherapy for colorectal cancer: current status and perspective].
    Kawamura Y; Konishi F
    Nihon Shokakibyo Gakkai Zasshi; 2007 Jul; 104(7):1018-24. PubMed ID: 17611378
    [No Abstract]   [Full Text] [Related]  

  • 17. The CAIRO and FOCUS studies: which lesson is to be learned?
    Koopman M; Seymour MT; Punt CJ
    Oncologist; 2009 Feb; 14(2):192-3; author reply 194-6. PubMed ID: 19251907
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolution of systemic therapy for metastatic colorectal cancer.
    Geh JI; Ma YT
    Colorectal Dis; 2011 Aug; 13(8):852-4. PubMed ID: 21762349
    [No Abstract]   [Full Text] [Related]  

  • 19. [5-fluorouracil and leucovorin therapy for advanced colorectal cancer].
    Shimoyama S; Kondo K; Kataoka M
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():356-9. PubMed ID: 14574912
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progress of chemotherapy in colorectal cancer].
    Komatsu Y
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1771-6. PubMed ID: 18064761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.